Literature DB >> 1319359

Vanadate increases cell surface insulin binding and improves insulin sensitivity in both normal and insulin-resistant rat adipocytes.

J W Eriksson1, P Lönnroth, U Smith.   

Abstract

The aim of this study was to elucidate the acute effects of vanadate on cell surface insulin binding and insulin sensitivity in rat adipocytes. The cells were preincubated at 37 degrees for 20 min followed by energy depletion with potassium cyanide, extensive washing and 125I-insulin binding. The presence of vanadate or insulin during the preincubation period dose-dependently enhanced 125I-insulin binding to normal adipocytes (maximally 4-5-fold) through an increased number of binding sites without any change in receptor affinity. Submaximal concentrations of vanadate added together with insulin enhanced the cellular sensitivity to the effect of insulin to stimulate 3-O-methylglucose transport. Vanadate, but not insulin, was also capable of increasing insulin binding as well as insulin sensitivity in insulin-resistant cells (treatment with N6-monobutyryl cAMP or amiloride and adipocytes from obese, aging rats). There was a correlation between the effect of vanadate to augment insulin binding and its ability to enhance cellular insulin sensitivity. Thus, the data suggest that short-term vanadate treatment improves insulin sensitivity through enhanced receptor binding and that this occurs in both normal and insulin-resistant cells.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1319359     DOI: 10.1007/bf00400477

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  35 in total

1.  The interaction between the adenylate cyclase system and insulin-stimulated glucose transport. Evidence for the importance of both cyclic-AMP-dependent and -independent mechanisms.

Authors:  P Lönnroth; J I Davies; I Lönnroth; U Smith
Journal:  Biochem J       Date:  1987-05-01       Impact factor: 3.857

2.  Transphosphorylation as a possible mechanism for insulin and epidermal growth factor receptor activation.

Authors:  R Lammers; E Van Obberghen; R Ballotti; J Schlessinger; A Ullrich
Journal:  J Biol Chem       Date:  1990-10-05       Impact factor: 5.157

3.  Kinetic parameters of transport of 3-O-methylglucose and glucose in adipocytes.

Authors:  R R Whitesell; J Gliemann
Journal:  J Biol Chem       Date:  1979-06-25       Impact factor: 5.157

4.  Internalization and degradation of fat cell-bound insulin. Separation and partial characterization of subcellular vesicles associated with iodoinsulin.

Authors:  K Suzuki; T Kono
Journal:  J Biol Chem       Date:  1979-10-10       Impact factor: 5.157

5.  Correction of chronic hyperglycemia with vanadate, but not with phlorizin, normalizes in vivo glycogen repletion and in vitro glycogen synthase activity in diabetic skeletal muscle.

Authors:  L Rossetti; M R Lauglin
Journal:  J Clin Invest       Date:  1989-09       Impact factor: 14.808

6.  Vanadate normalizes hyperglycemia in two mouse models of non-insulin-dependent diabetes mellitus.

Authors:  J Meyerovitch; P Rothenberg; Y Shechter; S Bonner-Weir; C R Kahn
Journal:  J Clin Invest       Date:  1991-04       Impact factor: 14.808

7.  Down-regulation of cell surface insulin receptors in primary cultured rat adipocytes by sodium vanadate.

Authors:  S Marshall; R Monzon
Journal:  Endocrinology       Date:  1987-09       Impact factor: 4.736

8.  Cyclic AMP modulates insulin binding and induces post-receptor insulin resistance of glucose transport in isolated rat adipocytes.

Authors:  D Kirsch; W Kemmler; H U Häring
Journal:  Biochem Biophys Res Commun       Date:  1983-08-30       Impact factor: 3.575

9.  Effect of vanadate on elevated blood glucose and depressed cardiac performance of diabetic rats.

Authors:  C E Heyliger; A G Tahiliani; J H McNeill
Journal:  Science       Date:  1985-03-22       Impact factor: 47.728

10.  Effect of vanadate on the cellular accumulation of pp15, an apparent product of insulin receptor tyrosine kinase action.

Authors:  M Bernier; D M Laird; M D Lane
Journal:  J Biol Chem       Date:  1988-09-25       Impact factor: 5.157

View more
  9 in total

Review 1.  Modulation of insulin action by vanadate: evidence of a role for phosphotyrosine phosphatase activity to alter cellular signaling.

Authors:  I G Fantus; G Deragon; R Lai; S Tang
Journal:  Mol Cell Biochem       Date:  1995 Dec 6-20       Impact factor: 3.396

Review 2.  Multifunctional actions of vanadium compounds on insulin signaling pathways: evidence for preferential enhancement of metabolic versus mitogenic effects.

Authors:  I G Fantus; E Tsiani
Journal:  Mol Cell Biochem       Date:  1998-05       Impact factor: 3.396

3.  Reversal of defective G-proteins and adenylyl cyclase/cAMP signal transduction in diabetic rats by vanadyl sulphate therapy.

Authors:  M B Anand-Srivastava; J H McNeill; X P Yang
Journal:  Mol Cell Biochem       Date:  1995 Dec 6-20       Impact factor: 3.396

4.  Inhibition of cyclic AMP dependent protein kinase by vanadyl sulfate.

Authors:  Kioumars A Jelveh; Rachel Zhande; Roger W Brownsey
Journal:  J Biol Inorg Chem       Date:  2006-02-28       Impact factor: 3.358

5.  Peroxovanadate but not vanadate exerts insulin-like effects in human adipocytes.

Authors:  P Lönnroth; J W Eriksson; B I Posner; U Smith
Journal:  Diabetologia       Date:  1993-02       Impact factor: 10.122

6.  The effect of vanadyl treatment on vascular responsiveness of streptozotocin-diabetic rats.

Authors:  A T Ozçelikay; C Pekiner; N Ari; Y Oztürk; A Ozüari; V M Altan
Journal:  Diabetologia       Date:  1994-06       Impact factor: 10.122

7.  A stable peroxovanadium compound with insulin-like action in human fat cells.

Authors:  J W Eriksson; P Lönnroth; B I Posner; A Shaver; C Wesslau; U P Smith
Journal:  Diabetologia       Date:  1996-02       Impact factor: 10.122

8.  Tissue-specific correction of lipogenic enzyme gene expression in diabetic rats given vanadate.

Authors:  S M Brichard; L N Ongemba; J Girard; J C Henquin
Journal:  Diabetologia       Date:  1994-11       Impact factor: 10.122

Review 9.  Insulin receptor-associated protein tyrosine phosphatase(s): role in insulin action.

Authors:  P G Drake; B I Posner
Journal:  Mol Cell Biochem       Date:  1998-05       Impact factor: 3.842

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.